Sangamo Therapeutics
SGMO
#9117
Rank
โ‚ฌ0.10 B
Marketcap
0,26ย โ‚ฌ
Share price
15.38%
Change (1 day)
-56.65%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -โ‚ฌ97.81 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ32.87 Million. In 2024 the company made an earning of -โ‚ฌ85.45 Million, an increase over its 2023 earnings that were of -โ‚ฌ0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ97.81 Million14.47%
2024 -โ‚ฌ85.45 Million-17.27%
2023 -โ‚ฌ0.11 Billion-40.88%
2022 -โ‚ฌ0.18 Billion9.79%
2021 -โ‚ฌ0.16 Billion41.52%
2020 -โ‚ฌ0.12 Billion23.17%
2019 -โ‚ฌ91.29 Million36.33%
2018 -โ‚ฌ66.96 Million36.89%
2017 -โ‚ฌ48.92 Million-22.32%
2016 -โ‚ฌ62.98 Million54.86%
2015 -โ‚ฌ40.67 Million75.62%
2014 -โ‚ฌ23.16 Million0.13%
2013 -โ‚ฌ23.13 Million
2011 -โ‚ฌ31.09 Million43.66%
2010 -โ‚ฌ21.65 Million28.52%
2009 -โ‚ฌ16.84 Million-23.55%
2008 -โ‚ฌ22.03 Million2.45%
2007 -โ‚ฌ21.5 Million19.5%
2006 -โ‚ฌ18 Million50.78%
2005 -โ‚ฌ11.94 Million75%
2004 -โ‚ฌ6.82 Million-33.25%
2003 -โ‚ฌ10.22 Million-62.27%
2002 -โ‚ฌ27.08 Million102.82%
2001 -โ‚ฌ13.35 Million23.21%
2000 -โ‚ฌ10.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ29.11 B-30,874.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.79 B-8,332.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ1.35 B-1,527.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-โ‚ฌ2.18 Billion 2,203.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ8.50 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ19.46 B-20,666.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ0.49 B-628.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.41 B-542.54%๐Ÿ‡บ๐Ÿ‡ธ USA